Thromboembolic risk of tamoxifen in patients with stage II breast cancer
- PMID: 2610746
- DOI: 10.1200/JCO.1989.7.10.1579
Thromboembolic risk of tamoxifen in patients with stage II breast cancer
Comment on
-
Doxorubicin-containing regimens for the treatment of stage II breast cancer: The National Surgical Adjuvant Breast and Bowel Project experience.J Clin Oncol. 1989 May;7(5):572-82. doi: 10.1200/JCO.1989.7.5.572. J Clin Oncol. 1989. PMID: 2651576 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
